Skip to content

← All news

Markets

Mineralys Therapeutics CMO David Rodman sells $58,785 in stock

1 source ·1 article ·Aug 13, 01:18 UTC Mineralys Therapeutics

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·Aug 13, 01:18 UTC

Mineralys Therapeutics CMO David Rodman sells $58,785 in stock